Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
ACS Nano ; 17(1): 372-381, 2023 01 10.
Artículo en Inglés | MEDLINE | ID: mdl-36534782

RESUMEN

Ferritin is the primary storage protein in our body and is of significant interest in biochemistry, nanotechnology, and condensed matter physics. More specifically within this sphere of interest are the magnetic properties of the iron core of ferritin, which have been utilized as a contrast agent in applications such as magnetic resonance imaging. This magnetism depends on both the number of iron atoms present, L, and the nature of the magnetic ordering of their electron spins. In this work, we create a series of ferritin samples containing homogeneous iron loads and apply diamond-based quantum spin relaxometry to systematically study their room temperature magnetic properties. We observe anomalous magnetic behavior that can be explained using a theoretical model detailing a morphological change to the iron core occurring at relatively low iron loads. This model provides an L0.35±0.06 scaling of the uncompensated Fe spins, in agreement with previous theoretical predictions. The necessary inclusion of this morphological change within the model is also supported by electron microscopy studies of ferritin with low iron content. This provides evidence for a magnetic consequence of this morphological change and positions diamond-based quantum spin relaxometry as an effective, noninvasive tool for probing the magnetic properties of metalloproteins. The low detection limit (ferritin 2% loaded at a concentration of 7.5 ± 0.4 µg/mL) also makes this a promising method for precision applications where low analyte concentrations are unavoidable, such as in biological research or even clinical analysis.


Asunto(s)
Ferritinas , Metaloproteínas , Hierro , Diamante , Nanopartículas Magnéticas de Óxido de Hierro
2.
Cogn Sci ; 46(6): e13146, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35665531

RESUMEN

Gender associations have been a long-standing research topic in psychological and social sciences. Although it is known that children learn aspects of gender associations at a young age, it is not well understood how they might emerge through the course of development. We investigate whether gender associations, such as the association of dresses with women and bulldozers with men, are reflected in the linguistic communication of young children from ages 1-5. Drawing on recent methods from machine learning, we use word embeddings derived from large text corpora including news articles and web pages as a proxy for gender associations in society, and we compare those with the gender associations of words uttered by caretakers and children in children's linguistic environment. We quantify gender associations in childhood language through gender probability, which measures the extent to which word usage frequencies in speech to and by girls and boys are gender-skewed. By analyzing 4,875 natural conversations between children and their caretakers in North America, we find that frequency patterns in word usage of both caretakers and children correlate strongly with the gender associations captured in word embeddings through the course of development. We discover that these correlations diminish from the 1970s to the 1990s. Our work suggests that early linguistic communication and social changes may jointly contribute to the formation of gender associations in childhood.


Asunto(s)
Desarrollo del Lenguaje , Lenguaje , Niño , Lenguaje Infantil , Preescolar , Femenino , Humanos , Lactante , Lingüística , Masculino , Habla
3.
Clin Chem Lab Med ; 59(3): 459-471, 2021 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-33090965

RESUMEN

Iron is a highly important metal ion cofactor within the human body, necessary for haemoglobin synthesis, and required by a wide range of enzymes for essential metabolic processes. Iron deficiency and overload both pose significant health concerns and are relatively common world-wide health hazards. Effective measurement of total iron stores is a primary tool for both identifying abnormal iron levels and tracking changes in clinical settings. Population based data is also essential for tracking nutritional trends. This review article provides an overview of the strengths and limitations associated with current techniques for diagnosing iron status, which sets a basis to discuss the potential of a new serum marker - ferritin-bound iron - and the improvement it could offer to iron assessment.


Asunto(s)
Deficiencias de Hierro , Anemia Ferropénica/diagnóstico , Biomarcadores , Ferritinas , Humanos , Hierro/metabolismo
4.
Can J Nurs Res ; 44(2): 86-106, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22894008

RESUMEN

The authors briefly introduce a clinical outreach initiative that is innovative because of the types of partnerships that have been formed within an inner-city community context. The initiative was designed to foster access to primary health care and specialized services for children and families who are vulnerable because of their social and material circumstances.Through ongoing engagement and dialogue, the clinicians and the community have developed a number of points of engagement with the children and families.The authors use the case of Learning Circles to describe ways in which Indigenous knowledge and ways of being influenced the approaches taken to working with children and families. They reflect upon the ways in which this approach influenced community engagement and consider its potential for achieving health equity.


Asunto(s)
Redes Comunitarias/organización & administración , Promoción de la Salud/organización & administración , Indígenas Norteamericanos , Atención Primaria de Salud/organización & administración , Enfermería Transcultural/organización & administración , Adulto , Canadá , Niño , Salud de la Familia , Humanos , Evaluación de Programas y Proyectos de Salud , Población Urbana
5.
J Pept Sci ; 18(6): 383-93, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22565812

RESUMEN

The identification of leptin as a mediator of body weight regulation provided much initial excitement for the treatment of obesity. Unfortunately, leptin monotherapy is insufficient in reversing obesity in rodents or humans. Recent findings suggest that amylin is able to restore leptin sensitivity and when used in combination with leptin enhances body weight loss in obese rodents and humans. However, as the uniqueness of this combination therapy remains unclear, we assessed whether co-administration of leptin with other weight loss-inducing hormones equally restores leptin responsiveness in diet-induced obese (DIO) mice. Accordingly, we report here the design and characterization of a series of site-specifically enhanced leptin analogs of high potency and sustained action that, when administered in combination with exendin-4 or fibroblast growth factor 21 (FGF21), restores leptin responsiveness in DIO mice after an initial body weight loss of 30%. Using either combination, body weight loss was enhanced compared with either exendin-4 or FGF21 monotherapy, and leptin alone was sufficient to maintain the reduced body weight. In contrast, leptin monotherapy proved ineffective when identical weight loss was induced by caloric restriction alone over a comparable time. Accordingly, we find that a hypothalamic counter-regulatory response to weight loss, assessed using changes in hypothalamic agouti related peptide (AgRP) levels, is triggered by caloric restriction, but blunted by treatment with exendin-4. We conclude that leptin re-sensitization requires pharmacotherapy but does not appear to be restricted to a unique signaling pathway. Our findings provide preclinical evidence that high activity, long-acting leptin analogs are additively efficacious when used in combination with other weight-lowering agents.


Asunto(s)
Dieta/efectos adversos , Factores de Crecimiento de Fibroblastos/farmacología , Leptina/análogos & derivados , Leptina/farmacología , Obesidad/metabolismo , Péptidos/farmacología , Ponzoñas/farmacología , Animales , Peso Corporal , Combinación de Medicamentos , Exenatida , Factores de Crecimiento de Fibroblastos/administración & dosificación , Leptina/administración & dosificación , Leptina/uso terapéutico , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Modelos Moleculares , Obesidad/inducido químicamente , Obesidad/tratamiento farmacológico , Péptidos/administración & dosificación , Polietilenglicoles/química , Ponzoñas/administración & dosificación
6.
PLoS One ; 7(3): e32631, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22412899

RESUMEN

Targeted deletion of S6 kinase (S6K) 1 in mice leads to higher energy expenditure and improved glucose metabolism. However, the molecular mechanisms controlling these effects remain to be fully elucidated. Here, we analyze the potential role of dietary lipids in regulating the mTORC1/S6K system. Analysis of S6K phosphorylation in vivo and in vitro showed that dietary lipids activate S6K, and this effect is not dependent upon amino acids. Comparison of male mice lacking S6K1 and 2 (S6K-dko) with wt controls showed that S6K-dko mice are protected against obesity and glucose intolerance induced by a high-fat diet. S6K-dko mice fed a high-fat diet had increased energy expenditure, improved glucose tolerance, lower fat mass gain, and changes in markers of lipid metabolism. Importantly, however, these metabolic phenotypes were dependent upon dietary lipids, with no such effects observed in S6K-dko mice fed a fat-free diet. These changes appear to be mediated via modulation of cellular metabolism in skeletal muscle, as shown by the expression of genes involved in energy metabolism. Taken together, our results suggest that the metabolic functions of S6K in vivo play a key role as a molecular interface connecting dietary lipids to the endogenous control of energy metabolism.


Asunto(s)
Grasas de la Dieta/metabolismo , Metabolismo de los Lípidos , Proteínas Quinasas S6 Ribosómicas/metabolismo , Aminoácidos de Cadena Ramificada/metabolismo , Animales , Línea Celular , Colesterol/sangre , Dieta Alta en Grasa/efectos adversos , Activación Enzimática , Ácidos Grasos/metabolismo , Ácidos Grasos no Esterificados/metabolismo , Femenino , Eliminación de Gen , Intolerancia a la Glucosa/genética , Intolerancia a la Glucosa/prevención & control , Leptina/sangre , Metabolismo de los Lípidos/genética , Masculino , Ratones , Ratones Noqueados , Músculo Esquelético/metabolismo , Obesidad/genética , Obesidad/metabolismo , Fenotipo , Proteínas Quinasas S6 Ribosómicas/deficiencia , Proteínas Quinasas S6 Ribosómicas/genética , Triglicéridos/sangre
7.
Artículo en Inglés | MEDLINE | ID: mdl-22649381

RESUMEN

OBJECTIVE: Ghrelin, a stomach-derived, secreted peptide, and its receptor (growth hormone secretagogue receptor, GHSR) are known to modulate food intake and energy homeostasis. The ghrelin system is also expressed broadly in cardiovascular tissues. Since ghrelin has been associated with anti-inflammatory and anti-atherogenic properties, but is also well known to promote obesity and impair glucose metabolism, we investigated whether ghrelin has any impact on the development of atherosclerosis. The hypothesis that endogenous ghrelin signaling may be involved in atherosclerosis has not been tested previously. METHODS AND RESULTS: We crossed ghrelin receptor knockout mice (GHSr(-/-)) into a low-density lipoprotein receptor-null (Ldlr(-/-)) mouse line. In this model, atherosclerotic lesions were promoted by feeding a high-fat, high-cholesterol Western-type diet for 13 months, following a standard protocol. Body composition and glucose homeostasis were similar between Ldlr(-/-) and Ldlr/GHSR(-/-)ko mice throughout the study. Absence or presence of GHSr did not alter the apolipoprotein profile changes in response to diet exposure on an LDLRko background. Atherosclerotic plaque volume in the aortic arch and thoracic aorta were also not affected differentially in mice without ghrelin signaling due to GHSR gene disruption as compared to control LDLRko littermates. In light of the associations reported for ghrelin with cardiovascular disease in humans, the lack of a phenotype in these loss-of-function studies in mice suggests no direct role for endogenous ghrelin in either the inhibition or the promotion of diet-induced atherosclerosis. CONCLUSION: These data indicate that, surprisingly, the complex and multifaceted actions of endogenous ghrelin receptor mediated signaling on the cardiovascular system have minimal direct impact on atherosclerotic plaque progression as based on a loss-of-function mouse model of the disease.

8.
Nat Neurosci ; 13(7): 877-82, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20526334

RESUMEN

Cholesterol circulates in the blood in association with triglycerides and other lipids, and elevated blood low-density lipoprotein cholesterol carries a risk for metabolic and cardiovascular disorders, whereas high-density lipoprotein (HDL) cholesterol in the blood is thought to be beneficial. Circulating cholesterol is the balance among dietary cholesterol absorption, hepatic synthesis and secretion, and the metabolism of lipoproteins by various tissues. We found that the CNS is also an important regulator of cholesterol in rodents. Inhibiting the brain's melanocortin system by pharmacological, genetic or endocrine mechanisms increased circulating HDL cholesterol by reducing its uptake by the liver independent of food intake or body weight. Our data suggest that a neural circuit in the brain is directly involved in the control of cholesterol metabolism by the liver.


Asunto(s)
HDL-Colesterol/sangre , Ghrelina/fisiología , Hipotálamo/metabolismo , Hígado/metabolismo , Melanocortinas/metabolismo , Animales , Peso Corporal , Antígenos CD36/metabolismo , Ingestión de Alimentos , Ghrelina/genética , Péptido 1 Similar al Glucagón/fisiología , Homeostasis/fisiología , Ratones , Ratones Noqueados , Sistemas Neurosecretores/metabolismo , Ratas , Ratas Wistar , Receptores de Melanocortina/genética , Receptores de Melanocortina/fisiología , Receptores Depuradores de Clase B/metabolismo
9.
Nat Chem Biol ; 5(10): 749-57, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19597507

RESUMEN

We report the efficacy of a new peptide with agonism at the glucagon and GLP-1 receptors that has potent, sustained satiation-inducing and lipolytic effects. Selective chemical modification to glucagon resulted in a loss of specificity, with minimal change to inherent activity. The structural basis for the co-agonism appears to be a combination of local positional interactions and a change in secondary structure. Two co-agonist peptides differing from each other only in their level of glucagon receptor agonism were studied in rodent obesity models. Administration of PEGylated peptides once per week normalized adiposity and glucose tolerance in diet-induced obese mice. Reduction of body weight was achieved by a loss of body fat resulting from decreased food intake and increased energy expenditure. These preclinical studies indicate that when full GLP-1 agonism is augmented with an appropriate degree of glucagon receptor activation, body fat reduction can be substantially enhanced without any overt adverse effects.


Asunto(s)
Péptido 1 Similar al Glucagón/agonistas , Obesidad/tratamiento farmacológico , Péptidos Cíclicos/uso terapéutico , Polietilenglicoles/química , Receptores de Glucagón/agonistas , Tejido Adiposo/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Peso Corporal/efectos de los fármacos , AMP Cíclico/biosíntesis , Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Prueba de Tolerancia a la Glucosa , Ratones , Ratones Obesos , Modelos Moleculares , Datos de Secuencia Molecular , Péptidos Cíclicos/química , Péptidos Cíclicos/farmacología , Conformación Proteica
10.
Diabetes ; 57(1): 5-12, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17914034

RESUMEN

OBJECTIVE: Apolipoprotein E (ApoE) regulates plasma lipid levels via modulation of lipolysis and serving as ligand for receptor-mediated clearance of triglyceride (TG)-rich lipoproteins. This study tested the impact of modulating lipid delivery to tissues on insulin responsiveness and diet-induced obesity. RESEARCH DESIGN AND METHODS: ApoE(+/+) and apoE(-/-) mice were placed on high-fat-high-sucrose diabetogenic diet or control diet for 24 weeks. Plasma TG clearance, glucose tolerance, and tissue uptake of dietary fat and glucose were assessed. RESULTS: Plasma TG clearance and lipid uptake by adipose tissue were impaired, whereas glucose tolerance was improved in control diet-fed apoE(-/-) mice compared with apoE(+/+) mice after an oral lipid load. Fat mass was reduced in apoE(-/-) mice compared with apoE(+/+) mice under both dietary conditions. The apoE(-/-) mice exhibited lower body weight and insulin levels than apoE(+/+) mice when fed the diabetogenic diet. Glucose tolerance and uptake by muscle and brown adipose tissue (BAT) was also improved in mice lacking apoE when fed the diabetogenic diet. Indirect calorimetry studies detected no difference in energy expenditure and respiratory quotient between apoE(+/+) and apoE(-/-) mice on control diet. Energy expenditure and uncoupling protein-1 expression in BAT were slightly but not significantly increased in apoE(-/-) mice on diabetogenic diet. CONCLUSIONS: These results demonstrated that decreased lipid delivery to insulin-sensitive tissues improves insulin sensitivity and ameliorates diet-induced obesity.


Asunto(s)
Apolipoproteínas E/deficiencia , Lípidos/sangre , Animales , Glucemia/metabolismo , Desoxiglucosa/metabolismo , Dieta para Diabéticos , Metabolismo Energético , Prueba de Tolerancia a la Glucosa , Lipoproteínas/sangre , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Triglicéridos/sangre , Tritio
11.
J Clin Invest ; 117(11): 3271-82, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17948131

RESUMEN

Diet-induced obesity and its serious consequences such as diabetes, cardiovascular disease, and cancer are rapidly becoming a major global health threat. Therefore, understanding the cellular and molecular mechanisms by which dietary fat causes obesity and diabetes is of paramount importance in order to identify preventive and therapeutic strategies. Increased dietary fat intake results in high plasma levels of triglyceride-rich lipoproteins (TGRL). Tissue uptake of TGRL has been shown to promote glucose intolerance. We generated mice with an adipocyte-specific inactivation of the multifunctional receptor LDL receptor-related protein-1 (LRP1) to determine its role in mediating the effects of TGRL on diet-induced obesity and diabetes. Knockout mice displayed delayed postprandial lipid clearance, reduced body weight, smaller fat stores, lipid-depleted brown adipocytes, improved glucose tolerance, and elevated energy expenditure due to enhanced muscle thermogenesis. We further demonstrated that inactivation of adipocyte LRP1 resulted in resistance to dietary fat-induced obesity and glucose intolerance. These findings identify LRP1 as a critical regulator of adipocyte energy homeostasis, where functional disruption leads to reduced lipid transport, increased insulin sensitivity, and muscular energy expenditure.


Asunto(s)
Adipocitos/metabolismo , Glucosa/metabolismo , Homeostasis , Metabolismo de los Lípidos , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Adipocitos/citología , Tejido Adiposo/anatomía & histología , Tejido Adiposo/metabolismo , Animales , Conducta Animal/fisiología , Transporte Biológico/fisiología , Dieta , Grasas de la Dieta , Metabolismo Energético , Intolerancia a la Glucosa/metabolismo , Lipoproteínas/metabolismo , Proteína 1 Relacionada con Receptor de Lipoproteína de Baja Densidad/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Obesidad/genética , Obesidad/metabolismo , Periodo Posprandial , Proteínas Supresoras de Tumor/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA